Archive for the ‘Autism’ Category

Netflix Currently Showing “Brain on Fire”

https://www.netflix.com/title/80128245

Stricken with seizures, psychosis and memory loss, a young New York Post reporter visits doctor after doctor in search of an elusive diagnosis.

  Approx. 9:30 Min

UK Interview with Susannah Cahalan who was diagnosed with a brain disorder called Autoimmune Encephalitis (AE)…7th Feb 2013

After reading the book a while back, I decided to watch the movie.  It’s a heart-wrenching story of another patient that almost got lost in the cracks and was misdiagnosed from everything from bipolar disorder to alcohol withdrawal.  It’s also another example of how a true physical problem can present like mental illness.

For more on this topic:  https://madisonarealymesupportgroup.com/2017/10/03/treat-the-infection-psychiatric-symptoms-get-better/

https://madisonarealymesupportgroup.com/2018/02/20/mysterious-disease-where-the-body-attacks-the-brain-more-common-than-initially-thought/  The Mayo Clinic’s new study, published in February in the journal Annals of Neurology, suggests that cases of autoimmune encephalitis aren’t nearly as rare as researchers once believed. By drawing on data from the Rochester Epidemiology Project, a medical records database in Olmsted County, Minnesota, the researchers were able to estimate that roughly 1 million people across the globe had autoimmune encephalitis at some point in their life. Each year, roughly 90,000 people may develop AE, they estimated.  “No prior studies evaluated this,” Eoin Flanagan, the lead author on the paper and an autoimmune neurology specialist at the Mayo Clinic, said in a statement.  Kelley, who is working on his own forthcoming study of the frequency of AE in young people, said his work echoes Flanagan’s findings.  “You can’t diagnose something you don’t know about, or that you don’t recognize,” Kelley told Business Insider.

In children, infections like strep throat appear to be a trigger of AE.  Susan Schulman, a pediatrician in New York, told Business Insider last year that she had seen hundreds of cases of a related condition, called PANS (pediatric acute-onset neuropsychiatric syndrome), in her patients. Her first case, in 1998, was a five-year old girl from Brooklyn who flew into a panic about keeping special holiday clothes separate from her regular clothes.  “She was driving her mother crazy,” Schulman said last year. At first, she believed the girl had childhood obsessive-compulsive disorder, but medication made the child’s symptoms worse. She later returned to Schulman’s office with a nasty case of strep throat and strangely, after Schulman treated the strep with antibiotics, the OCD symptoms vanished.

The reason we need to be aware of this issue is Lyme/MSIDS can also be a trigger:  https://madisonarealymesupportgroup.com/2017/10/01/panspandas-steroids-autoimmune-disease-lymemsids-the-need-for-medical-collaboration/

https://madisonarealymesupportgroup.com/2017/04/11/hidden-invaders-infections-can-trigger-immune-attacks-on-kids-brains-provoking-devastating-psychiatric-disorders/

https://madisonarealymesupportgroup.com/2017/06/30/child-with-lymemsidspans-told-by-doctors-she-made-it-all-up/

https://madisonarealymesupportgroup.com/2018/06/14/depression-the-radical-theory-linking-it-to-inflammation/

Study Links Food Allergy to Autism Spectrum Disorder in Children

https://www.public-health.uiowa.edu/news-items/study-links-food-allergy-to-autism-spectrum-disorder-in-children/

Study links food allergy to autism spectrum disorder in children

Published on June 15, 2018

Wei-Bao-130x182Assistant Professor Wei Bao of the Department of Epidemiology in the University of Iowa College of Public Health.

A new study from the University of Iowa finds that children with autism spectrum disorder (ASD) are more than twice as likely to suffer from a food allergy than children who do not have ASD.

Wei Bao, assistant professor of epidemiology at the UI College of Public Health and the study’s corresponding author, says the finding adds to a growing body of research that suggests immunological dysfunction as a possible risk factor for the development of ASD.

“It is possible that the immunologic disruptions may have processes beginning early in life, which then influence brain development and social functioning, leading to the development of ASD,” says Bao.

The study analyzed the health information of nearly 200,000 children gathered by the U.S. National Health Interview Survey (NHIS), an annual survey of American households conducted by the U.S. Centers for Disease Control and Prevention. The children were between the ages of 3 and 17 and the data were gathered between 1997 and 2016.

The study found that 11.25 percent of children reportedly diagnosed with ASD have a food allergy, significantly higher than the 4.25 percent of children who are not diagnosed with ASD and have a food allergy.

Bao says his study could not determine the causality of this relationship given its observational nature. But previous studies have suggested possible links—increased production of antibodies, immune system overreactions causing impaired brain function, neurodevelopmental abnormalities, and alterations in the gut biome. He says those connections warrant further investigation.

“We don’t know which comes first, food allergy or ASD,” says Bao, adding that another longitudinal follow-up study of children since birth would be needed to establish temporality.

He says previous studies on the association of allergic conditions with ASD have focused mainly on respiratory allergy and skin allergy, and those studies have yielded inconsistent and inconclusive results. The new study found 18.73 percent of children with ASD suffered from respiratory allergies, whereas only 12.08 percent of children without ASD had such allergies, and 16.81 percent of children with ASD had skin allergies, well above the 9.84 percent of children without ASD.

“This indicates there could be a shared mechanism linking different types of allergic conditions to ASD,” says Bao.

Bao says the study is limited in that the NHIS depends on respondents to voluntarily self-report health conditions, so the number of children with ASD or allergies may be misreported by those taking the survey. But he says the large number of respondents and ethnic and gender cross-representation of the survey are major strengths.

The study, “Association of Food Allergy and Other Allergic Conditions with Autism Spectrum Disorder in Children,” was published online in the June 8 issue of JAMA Network Open. The first author is Guifeng Xu, PhD candidate in the UI College of Public Health and graduate research assistant in the UI Roy J. and Lucille A. Carver College of Medicine. Additional co-authors include Linda G. Snetselaar, professor of epidemiology in the UI College of Public Health; Jin Jing, professor of maternal and child health at the Sun Yat-Sen University in China; Buyun Liu, postdoctoral researcher in the UI College of Public Health; and Lane Strathearn, professor of pediatrics in the Carver College of Medicine.

This story originally appeared in Iowa Now:  https://now.uiowa.edu/2018/06/ui-study-links-food-allergy-autism-spectrum-disorder-children

______________

For More:  https://madisonarealymesupportgroup.com/2018/06/15/canadian-data-more-autism-where-vaccine-coverage-is-highest/

https://madisonarealymesupportgroup.com/2017/09/19/autism-aluminum-adjuvant-link-corroborated/

https://madisonarealymesupportgroup.com/2018/06/01/immunoexcitotoxicity-as-the-central-mechanism-of-etiopathology-treatment-of-autism-spectrum-disorders-a-possible-role-of-fluoride-aluminum/

https://madisonarealymesupportgroup.com/2017/10/26/clinical-trial-shows-most-kids-with-autism-are-not-born-with-it/

https://madisonarealymesupportgroup.com/2018/06/25/success-of-blood-test-for-autism/

 

Success of Blood Test For Autism

https://www.sciencedaily.com/releases/2018/06/180619122434.htm

Success of blood test for autism affirmed

First physiological test for autism proves high accuracy in second trial

June 19, 2018
Rensselaer Polytechnic Institute

One year after researchers published their work on a physiological test for autism, a follow-up study confirms its exceptional success in assessing whether a child is on the autism spectrum. A physiological test that supports a clinician’s diagnostic process has the potential to lower the age at which children are diagnosed, leading to earlier treatment. Results of the study, which uses an algorithm to predict if a child has autism spectrum disorder (ASD) based on metabolites in a blood sample, published online today, appear in the June edition of Bioengineering & Translational Medicine.

“We looked at groups of children with ASD independent from our previous study and had similar success. We are able to predict with 88 percent accuracy whether children have autism,” said Juergen Hahn, lead author, systems biologist, professor, head of the Rensselaer Polytechnic Institute Department of Biomedical Engineering, and member of the Rensselaer Center for Biotechnology and Interdisciplinary Studies (CBIS). “This is extremely promising.”

It is estimated that approximately 1.7 percent of all children are diagnosed with ASD, characterized as “a developmental disability caused by differences in the brain,” according to the Centers for Disease Control and Prevention. Earlier diagnosis is generally acknowledged to lead to better outcomes as children engage in early intervention services, and an ASD diagnosis is possible at 18-24 months of age. However, because diagnosis depends solely on clinical observations, most children are not diagnosed with ASD until after 4 years of age.

Rather than search for a sole indicator of ASD, the approach Hahn developed uses big data techniques to search for patterns in metabolites relevant to two connected cellular pathways (a series of interactions between molecules that control cell function) with suspected links to ASD.

“Juergen’s work in developing a physiological test for autism is an example of how the interdisciplinary life science-engineering interface at Rensselaer brings new perspectives and solutions to improve human health,” said Deepak Vashishth, CBIS director. “This is a great result from the larger emphasis on Alzheimer’s and neurodegenerative diseases at CBIS, where our work joins multiple approaches to develop better diagnostic tools and biomanufacture new therapeutics.”

The initial success in 2017 analyzed data from a group of 149 people, about half of whom had been previously diagnosed with ASD. For each member of the group, Hahn obtained data on 24 metabolites related to the two cellular pathways — the methionine cycle and the transsulfuration pathway. Deliberately omitting data from one individual in the group, Hahn subjected the remaining dataset to advanced analysis techniques and used results to generate a predictive algorithm. The algorithm then made a prediction about the data from the omitted individual. Hahn cross-validated the results, swapping a different individual out of the group and repeating the process for all 149 participants. His method correctly identified 96.1 percent of all typically developing participants and 97.6 percent of the ASD cohort.

The results were impressive and created, said Hahn, a new goal: “Can we replicate this?”

The new study applies Hahn’s approach to an independent dataset. To avoid the lengthy process of gathering new data through clinical trials, Hahn and his team searched for existing datasets that included the metabolites he had analyzed in the original study. The researchers identified appropriate data from three different studies that included a total of 154 children with autism conducted by researchers at the Arkansas Children’s Research Institute. The data included only 22 of the 24 metabolites he used to create the original predictive algorithm, however Hahn determined the available information would be sufficient for the test.

The team used their approach to recreate the predictive algorithm, this time using data of the 22 metabolites from the original group of 149 children. The algorithm was then applied to the new group of 154 children for testing purposes. When the predictive algorithm was applied to each individual, it correctly predicted autism with 88 percent accuracy.

Hahn said the difference between the original accuracy rate and that of the new study can likely be attributed to several factors, the most important being that two of the metabolites were unavailable in the second dataset. Each of the two metabolites had been strong indicators in the previous study.

Overall, the second study validates the original results, and provides insights into several variants on the approach.

“The most meaningful result is the high degree of accuracy we are able to obtain using this approach on data collected years apart from the original dataset,” said Hahn. “This is an approach that we would like to see move forward into clinical trials and ultimately into a commercially available test.”

Hahn was joined on the research by Rensselaer doctoral students Troy Vargason and Daniel P. Howsmon; Robert A. Rubin of Whittier College; Leanna Delhey, Marie Tippett, Shannon Rose, and Sirish C. Bennuri of the Arkansas Children’s Research Institute and the University of Arkansas for Medical Sciences; John C. Slattery, Stepan Melnyk, and S. Jill James of the University of Arkansas for Medical Sciences; and Richard E. Frye of Phoenix Children’s Hospital. The research was partially funded by the National Institutes of Health.

Materials provided by Rensselaer Polytechnic Institute. Note: Content may be edited for style and length.

Journal Reference:

Daniel P. Howsmon, Troy Vargason, Robert A. Rubin, Leanna Delhey, Marie Tippett, Shannon Rose, Sirish C. Bennuri, John C. Slattery, Stepan Melnyk, S. Jill James, Richard E. Frye, Juergen Hahn. Multivariate techniques enable a biochemical classification of children with autism spectrum disorder versus typically-developing peers: A comparison and validation study. Bioengineering & Translational Medicine, 2018; DOI: 10.1002/btm2.10095

________________

**Comment**

Autism like Lyme/MSIDS is an epidemic and according to one Wisconsin LLMD, 80% of his Autistic patients are also infected with Lyme/MSIDS.

For more:

https://madisonarealymesupportgroup.com/2018/06/15/canadian-data-more-autism-where-vaccine-coverage-is-highest/

https://madisonarealymesupportgroup.com/2018/06/01/immunoexcitotoxicity-as-the-central-mechanism-of-etiopathology-treatment-of-autism-spectrum-disorders-a-possible-role-of-fluoride-aluminum/

https://madisonarealymesupportgroup.com/2017/10/26/clinical-trial-shows-most-kids-with-autism-are-not-born-with-it/

 

Canadian Data: More Autism Where Vaccine Coverage is Highest

https://worldmercuryproject.org/news/official-canadian-data-show-that-there-is-more-autism-in-regions-where-vaccine-coverage-is-highest/

APRIL 26, 2018

Official Canadian Data Show That There Is More Autism in Regions Where Vaccine Coverage Is Highest

By the World Mercury Project Team

Rates of autism spectrum disorder (ASD) continue to soar worldwide, with average prevalence estimated to be around 1.5% in developed countries. This estimate appears to be spot-on for Canada, which reported in March 2018 that autism (as of 2015) affected 1 in 66 children and youth (1.52%). These numbers place Canada among the “top ten” for autism among North American, European and Asian countries.

The Canadian public had been expecting the Public Health Agency of Canada to release these first-ever nationally representative ASD numbers since 2016. The data come from the National ASD Surveillance System (NASS), which, according to the Public Health Agency, is intended to pinpoint the number of young people diagnosed with ASD “both across regions and over time.” The Agency’s report provides answers on both fronts—showing steady increases in ASD prevalence since 2003 and notable differences across regions—but the document declines to speculate on factors that might account for the regional differences.

What might explain the variation in ASD prevalence within Canada’s borders? … autism prevalence is highest in the Canadian provinces that also have the highest vaccination coverage.

ASD prevalence by province and territory

NASS compiles administrative data from the health, education and social services sectors for children and youth (aged 5-17 years) who have a confirmed ASD diagnosis. Seven of Canada’s 13 provinces and territories provided information for 2015, including six provinces (British Columbia, New Brunswick, Newfoundland and Labrador, Nova Scotia, Prince Edward Island and Quebec) and one territory (Yukon). As the figure below shows, ASD prevalence in 2015 varied among the seven regions, with the highest prevalence noted in the three provinces of Newfoundland and Labrador (1 in 57), Prince Edward Island (1 in 59) and Quebec (1 in 65). In comparison, prevalence was substantially lower in the Yukon territory (1 in 125).

The three high-prevalence provinces also provided retrospective data that allowed for an assessment of temporal trends. For the slightly narrower age group of 5-14 year olds, the historical data showed sizeable increases in ASD prevalence from 2003 to 2015 (Prince Edward Island and Quebec) and from 2003 to 2009 (Newfoundland and Labrador):

  • Newfoundland and Labrador: from 6 to 19.6 per 1,000 (a 227% increase)
  • Prince Edward Island: from 5 to 17.7 per 1,000 (a 254% increase)
  • Quebec: from 3.5 to 15.7 per 1,000 (a 349% increase)

Explaining the regional differences

What might explain the variation in ASD prevalence within Canada’s borders? The NASS report does not offer any comments. However, an observant health practitioner in British Columbia has noticed a compelling parallel: autism prevalence is highest in the Canadian provinces that also have the highest vaccination coverage. This evidence comes from a 2013 survey carried out by the very same Public Health Agency of Canada, which examined vaccine coverage by province/territory and type of vaccine (see table). The survey showed that coverage by age two was generally lower (with a few exceptions) in Yukon territory than in the three high-autism provinces. For Newfoundland/Labrador and Quebec, the percentage point difference in vaccine coverage was anywhere from five to fifteen percentage points higher than in Yukon; Prince Edward Island’s lead in vaccine coverage compared to Yukon was less substantial.

Correlation is not causation but…

Any researcher worth their salt knows that while correlation is not the same as causation, a plausible association between two variables is often an important clue worth investigating. The substantially lower ASD prevalence in a region that happens to have markedly lower vaccine coverage is one such clue. Another strand of evidence that simply cannot be chalked up to coincidence are the tens of thousands of parental reports of children regressing into autism after receiving one or more vaccines. Unfortunately, Canadian parents who suspect that their autistic child was vaccine-injured have nowhere to turn, because Canada remains “one of few western countries that denies the reality of vaccine injuries and provides no avenue whatsoever to compensate vaccine injury victims and their families.” It would behoove Canada’s public health officials to take a closer look at their own data and start taking meaningful steps to prevent the country’s ASD numbers from climbing still further.

Note:  The CDC is due to release its latest ADDM surveillance numbers for the U.S.  Will our federal health agencies continue to downplay the numbers’ significance, as they have done each time the data show a rise in ASD prevalence? Or will they finally sound an alarm and make it a top priority to find out what is causing this epidemic in our children? 

_______________

For more:  https://madisonarealymesupportgroup.com/2018/06/01/immunoexcitotoxicity-as-the-central-mechanism-of-etiopathology-treatment-of-autism-spectrum-disorders-a-possible-role-of-fluoride-aluminum/

https://madisonarealymesupportgroup.com/2018/03/21/congress-receives-vaccine-safety-project-details-since-the-cdc-fda-ignore-their-own-data-and-proclaim-vaccines-do-not-cause-autism/

https://madisonarealymesupportgroup.com/2017/09/21/aluminum-flawed-assumptions-fueling-autoimmune-disease-and-lyme/

https://madisonarealymesupportgroup.com/2017/09/19/autism-aluminum-adjuvant-link-corroborated/

https://madisonarealymesupportgroup.com/2018/04/09/a-tale-of-3-metals-the-fate-of-western-civilization-what-we-can-do-about-it/

Immunoexcitotoxicity as the Central Mechanism of Etiopathology & Treatment of Autism Spectrum Disorders: A Possible Role of Fluoride & Aluminum

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909100/

Surg Neurol Int. 2018; 9: 74.

Published online 2018 Apr 9. doi:  10.4103/sni.sni_407_17
PMCID: PMC5909100
PMID: 29721353

Immunoexcitotoxicity as the central mechanism of etiopathology and treatment of autism spectrum disorders: A possible role of fluoride and aluminum

Abstract
Our review suggests that most autism spectrum disorder (ASD) risk factors are connected, either directly or indirectly, to immunoexcitotoxicity. Chronic brain inflammation is known to enhance the sensitivity of glutamate receptors and interfere with glutamate removal from the extraneuronal space, where it can trigger excitotoxicity over a prolonged period. Neuroscience studies have clearly shown that sequential systemic immune stimulation can activate the brain’s immune system, microglia, and astrocytes, and that with initial immune stimulation, there occurs CNS microglial priming.

Children are exposed to such sequential immune stimulation via a growing number of environmental excitotoxins, vaccines, and persistent viral infections. We demonstrate that fluoride and aluminum (Al3+) can exacerbate the pathological problems by worsening excitotoxicity and inflammation. While Al3+ appears among the key suspicious factors of ASD, fluoride is rarely recognized as a causative culprit. A long-term burden of these ubiquitous toxins has several health effects with a striking resemblance to the symptoms of ASD. In addition, their synergistic action in molecules of aluminofluoride complexes can affect cell signaling, neurodevelopment, and CNS functions at several times lower concentrations than either Al3+ or fluoride acting alone. Our review opens the door to a number of new treatment modes that naturally reduce excitotoxicity and microglial priming.

Table 2. Prevention & amelioration of ASD symptoms

SNI-9-74-g014

Excerpt from conclusion:

Evidence is presented that the abundance of fluoride added to the water worldwide and the widespread availability of aluminum particularly to infants and young children through aluminum containing vaccinations, singly or together as aluminofluoride can be potent factors in producing the condition of immunoexcitotoxicity that leads to the pathological changes seen in ASD. The vaccination program should be evaluated to reduce the excessive stimulation of immature immune system and to replace Al3+-adjuvants.

______________

For more:  https://madisonarealymesupportgroup.com/2017/10/26/clinical-trial-shows-most-kids-with-autism-are-not-born-with-it/

https://madisonarealymesupportgroup.com/2017/09/19/autism-aluminum-adjuvant-link-corroborated/

https://madisonarealymesupportgroup.com/2018/04/09/a-tale-of-3-metals-the-fate-of-western-civilization-what-we-can-do-about-it/

https://madisonarealymesupportgroup.com/2018/05/14/important-background-on-lyme-vaccine-controversy/  But, a lot has happened since both the 1998 Lyme vaccine and Weintraub’s 2008 book that declares the Lyme vaccine caused “rare” adverse events.
https://madisonarealymesupportgroup.com/2018/04/16/vl15-lyme-vaccine-another-fraud/ THIS VACCINE CAUSED 229 DEATHS, INCLUDING 43 SUICIDES
https://madisonarealymesupportgroup.com/2018/01/28/the-secret-x-files-the-untold-history-of-the-lymerix-vaccine/
https://madisonarealymesupportgroup.com/2018/04/16/vl15-lyme-vaccine-another-fraud/
https://madisonarealymesupportgroup.com/2017/07/01/pbs-lyme-vaccine/ Even in 2008, Drymon reported: Did you know that the LYMERIX vaccine caused 640 emergency room visits, 34 life threatening reactions, 77 hospitalizations, 198 disabilities, and 6 deaths? In a vile cesspool of conflicts of interest are university patent holders, drug companies, and the FDA itself as another patent holder. It generated 40 million dollars before it was yanked. (2008, Drymon)
As you can see in Dr. Lapenta’s article, the death toll raised to 229. Besides, death and suicide, please see:
http://www.yourlawyer.com/topics/overview/lymerix One doctor stated that 21 patients developed severe arthritis after receiving the LYMERIX vaccine.
http://www.lymediseaseassociation.org/index.php/about-lyme/controversy/vaccine/261-lymerix-meeting “Given that Dr. Marks lead the clinical trials for Lymerix’s competitor, the OspA vaccine produced and then abandoned by Aventis Pasteur, his conclusions mean a lot. “In my opinion,” he told FDA officials, “there is sufficient evidence that Lymerix is causally related to severe rheumatologic, neurologic, autoimmune, and other adverse events in some individuals. This evidence is such as to warrant a significantly heightened degree of warnings and possible limitations or removal from marketing of Lymerix.”

Dr. Stricker states:
Another Lyme OspA Vaccine Whitewash
The meta-analysis by Zhao and colleagues comes to the conclusion that “the OspA vaccine against Lyme disease is safe and its immunogenicity and efficacy have been verified.” The authors arrive at this sunny conclusion by excluding 99.6% of published articles that demonstrate potential problems with the OspA vaccine. Furthermore, the authors ignore peer-reviewed studies, FDA regulatory meetings and legal proceedings that point to major problems with OspA vaccine safety (1-3). This whitewash bodes ill for future Lyme vaccine candidates because it fosters disregard for vaccine safety among Lyme vaccine manufacturers and mistrust among potential Lyme vaccines.

 

 

 

Bill Gates, Are Vaccines a “Miracle” Over Disease & a “Fantastic Investment”….or a Disaster For Child Health That May Break the Bank?

Please note in the following article the stats that 1 in 6 children now have a development disorder such as Autism, as well as there may be as many as 1 in 200 with PANS/PANDAS.  Many of these kids also have Lyme/MSIDS.

https://worldmercuryproject.org/news/bill-gates-are-vaccines-a-miracle-over-disease-and-a-fantastic-investment/  January 03, 2018

Bill Gates, are vaccines a “miracle” over disease and a “fantastic investment”…— or a disaster for child health that may break the bank?

Bill-Gates-with-Vaccine_Featured_ImageBy World Mercury Project Team

Bill Gates is fond of using his bully pulpit to talk about “miracles” and “magic.” Gates has featured one or both words in nearly all of his annual wrap-up letters for the Bill & Melinda Gates Foundation (2009, 2010, 2011, 2012, 2014, 2016 and 2017), most often in reference to the Gates Foundation’s outsized financial and ideological support for global vaccine programs. As Gates says, “In the same way that during my Microsoft career I talked about the magic of software, I now spend my time talking about the magic of vaccines.”

Gates’s words give us an immediate clue that he is engaging in his own brand of magical thinking—which social scientists define as “illogical causal reasoning.” How else to explain his simplistic endorsement of vaccines as a miraculous intervention with unmitigated benefits and no down side? The Gates Foundation’s global spreadsheet appears to have no room to tally the massive flood of vaccine injuries afflicting children worldwide, despite abundant evidence that this damage is standing the vaccine risk-benefit calculus on its head and turning childhood into an extended round of Russian roulette.  https://worldmercuryproject.org/news/countering-false-vaccine-safety-claims/

Let’s report history accurately

In a widely cited 2014 blog post on the “miracle of vaccines,” Gates expressed enthusiasm about the “inspiring” data on vaccines and the “fantastic” and “phenomenal” progress being made to expand vaccine coverage. There is one major problem with Gates’ professed reliance on “data,” which is that the philanthropist ignores fundamental historical facts governing infectious disease and vaccine timelines.

There is one major problem with Gates’ professed reliance on “data,” which is that the philanthropist ignores fundamental historical facts governing infectious disease and vaccine timelines.

Vital statistics data reveal that in the U.S. and elsewhere, fatalities from diseases such as scarlet fever—in the absence of any vaccine—had become quite rare by the mid-20th century. Mortality from infectious diseases such as measles and whooping cough (pertussis) also had declined rapidly, well before the introduction of the corresponding vaccines (see Figure 1). A meticulous review of U.S. mortality data from 1900–1973 concluded:

“Medical measures [such as vaccines] contributed little to the overall decline in mortality in the United States since about 1900—having in many instances been introduced several decades after a marked decline had already set in.”

The same researchers, in another article, chastised the medical establishment for its misplaced confidence in “magic bullets” (there is that word “magic” again!). Instead, if the decline in infectious disease incidence and mortality in the last century represented any kind of “miracle,” the phenomenon was, by all honest accounts, attributable to classic and long-term public health measures such as better sanitation and, especially, improved nutrition. A study of 20th-century mortality trends in Italy found a significant association between increased caloric intake and declining mortality, reflecting “progress in average nutritional status, lifestyle quality, socioeconomic level and hygienic conditions.” Moreover, mortality dropped most sharply in Italy’s youngest age groups—who were “probably the most sensible to the changes in nutrition and wellness.” Even early 20th-century epidemiologists who were inclined to give some credit to vaccines recognized that other factors were at play, including changes in “human resistance and bacterial quality” as well as factors yet to be determined.

Figure 1. U.S. mortality rates, 1900–1963  Source: Data compiled from the National Office of Statistics.

01-03-Vaccines-Miracle-or-Disaster-1

Oh miracle, where art thou?

Even if one leaves 20th-century vital statistics behind, there is a glaring piece of evidence that gives the lie to Bill Gates’ disingenuous assertions about vaccine miracles: vaccines are not actually making or keeping children healthy. Instead, in the U.S. (where children are the most highly vaccinated in the world), over half of all young people have a chronic illness—a trend that coincides with the expansion of the nation’s vaccine schedule. Similar patterns of chronic illness are emerging worldwide, including for potentially life-threatening conditions such as food allergies and asthma.

…there is a glaring piece of evidence that gives the lie to Bill Gates’ disingenuous assertions about vaccine miracles: vaccines are not actually making or keeping children healthy.

The World Mercury Project’s Campaign to Restore Child Health has been documenting parents’ first-hand accounts of serious adverse outcomes experienced by their children following vaccination. These testimonials, which represent the tip of the iceberg, cover a panoply of disorders that were rare or even unheard of a few decades ago:

  • Thirteen percent of U.S. children are in special education.
  • One in six American children has a developmental disorder such as autism spectrum disorder (ASD).
  • Attention-deficit/hyperactivity disorder (ADHD) affects nearly 11% of American children.
  • One in 20 children under the age of five has epilepsy.
  • Peanut allergies are the most common cause of food-related death.
  • Women who receive flu and Tdap vaccines during pregnancy are at greater risk of miscarriages and other problems.
  • Pediatric autoimmune neuropsychiatric disorders associated with streptococcal or other infections (PANDAS or PANS) may affect as many as 1 in 200 children in the U.S., including up to 25% of children diagnosed with obsessive-compulsive disorder (OCD) and tic disorders.
  • Sensory processing disorder (SPD) often co-occurs with ADHD and ASD.
  • In the U.S., the infant mortality rate, including from sudden infant death syndrome (SIDS), is double the rate in many other high-income countries. In Africa, a comparative study in Guinea-Bissau found that infant mortality was at least twice as high (10%-11%) in children who received the diphtheria-tetanus-pertussis (DTP) and polio vaccines as in children who did not receive the vaccines (4%-5%).

…large foundations such as the Bill & Melinda Gates Foundation exert influence not just through their “enormous resources” but also “by shaping development concepts and policies.”

Cui bono?

A recent German report on global philanthropy observes that modern philanthropy has its roots, first and foremost, in business tycoons’ self-interested desire to shield income from taxation while “garner[ing] prestige and influence in the U.S. and world affairs.” The report’s authors note that large foundations such as the Bill & Melinda Gates Foundation exert influence not just through their “enormous resources” but also “by shaping development concepts and policies.” The Gates Foundation—established in 2000 with an initial endowment of $42.9 billion and amplified by an additional $30 billion from Warren Buffet in 2006—has become the world’s leading global health player as well as the largest non-state funder of the World Health Organization (WHO). As a result of the Gates Foundation’s “tremendous agenda-setting power,” the global health community designated 2010–2020 as the Decade of Vaccines; developed a Global Vaccine Action Plan; and created the public-private Global Alliance for Vaccines and Immunization (GAVI Alliance), which receives almost one-fourth of its funding from the Gates Foundation.

While Gates has rhapsodized that vaccines are a fantastic investment, the vaccine industry, in fact, is a primary beneficiary of Gates Foundation largesse. According to the German analysts, for example, the Gates Foundation’s support of the GAVI Alliance has incentivized manufacturers to increase production of specific vaccines. These incentives have resulted in payments of over $1 billion to Pfizer and GlaxoSmithKline (GSK). Some reporters have described this arrangement as “a leg-up for pharmaceutical companies ‘seeking to expand into faster-growing, lower-income countries.’” However, as the German report notes, the non-governmental organization Doctors without Borders (MSF) has questioned the GAVI Alliance’s overall impact on vaccine affordability, stating that “the cost to fully immunize a child was 68 times more expensive in 2014 than it was in 2001.”

The German analysts and others have outlined key features of the Gates Foundation’s close partnership with the pharmaceutical industry, including the revolving door between the staff of the Foundation and pharmaceutical companies such as Merck and GSK…
The German analysts and others have outlined key features of the Gates Foundation’s close partnership with the pharmaceutical industry, including the revolving door between the staff of the Foundation and pharmaceutical companies such as Merck and GSK; the preponderant focus of the Foundation’s largest global health awards (20/50 or 40%) on research and development of new vaccines and drugs; and the Foundation’s $52 million equity stake in CureVac (a German pharmaceutical company) to speed up development of mRNA-vaccines. The Gates Foundation also has increased its direct support for the biotechnology industry, which is of considerable relevance to the vaccine industry due to the rapidly increasing use of biotech in modern vaccine manufacturing. Recent articles have pointed out, moreover, that the Gates Foundation routinely pays public relations firms to manipulate scientific decision-making in favor of the risky genetic engineering technologies that the Foundation supports.  https://www.independentsciencenews.org/news/gates-foundation-hired-pr-firm-to-manipulate-un-over-gene-drives/

What these observations make apparent is that Bill Gates’s vaccine philanthropy indeed represents a “miracle”—but the miracle’s beneficiaries are the corporations and stockholders who are laughing all the way to the bank, and certainly not the children and adults around the world who are bearing the brunt of unsafe vaccines. Dr. Arata Kochi, the WHO’s former director of malaria research, chose to call a spade a spade in 2008 when he described the Gates Foundation as a cartel that suppresses diversity of scientific opinion and is “accountable to no one other than itself.”

 

 

 

20K Needed For Vaccine Mutation Study

For those of you who read my posts you understand I post information about vaccines due to their ability to reactivate latent infections such as Lyme/MSIDS.  Besides that, there can be vaccine contamination and ingredients that can worsen a chronically ill person’s condition.

Logo80tall

Sound Choice Pharmaceutical Institute, an independent research institute, does cutting edge research, and seeks to raise awareness about vaccine health risks & specifically studies the issue of human fetal cell lines in vaccines and how the insertions can disrupt the function of the invaded cell. Since many scientists have hypothesized that cancer and other childhood neurological diseases such as Autism are caused by mutations in the child’s DNA, this research is paramount in teasing out what is causing or exacerbating what.

Recently, in April, SCPI raised $80,000 to complete a double-blind, placebo vaccine mutation study, but are short $20,000 for this goal.

Please consider giving for this end.  They are hoping to reach their goal today and tomorrow.

If we ever needed answers on the vaccine issue, it is now.  With nearly 1 in 60 children diagnosed with Autism, it’s a literal epidemic, and according to a highly respected Wisconsin LLMD, 80% of his Autistic patients have an underlying Lyme/MSIDS infection. To say it’s a big deal is an understatement.

To Give, go here:  https://www.givebigseattle.org/sound-choice-pharmaceutical-institute

To read more about SCPI’s, focus, research, newsletter:  http://soundchoice.org/

SCSI Scientists speak up on Vaccine Outrage: http://soundchoice.org/newsletter-march-2017/

Vaccine card:  http://soundchoice.org/wp-content/uploads/vaccineListOrigFormat.pdf

I for one am excited that there are independent researchers dedicated to doing the proper studies.  Please consider helping them out.